Company / Free Cash Flow
Glaukos Corp. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$22.5M
FY2025
5-year range
-$78.0M / -$22.5M
FY2021-FY2025
Trend
+66.8%
vs FY2024
Sector context
#121 of 145
Health Care
What the data says
Glaukos Corp.'s free cash flow of -$22M is lower than 83% of companies in the Health Care sector (FY2025). Free Cash Flow has fluctuated over the past 10 years, ranging from -$78M in FY2023 to $20M in FY2017.
Based on SEC 10-K filings.
-$22M in FY2025.
Improved from -$78M to -$22M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 145This company -$22.5M Sector average $770.9M
▼
-102.9% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 66.8% year-over-year.
- Ranks #121 out of 145 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2017.
- Lowest free cash flow in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$22.5M | +66.8% |
| FY2024 | -$67.6M | +13.3% |
| FY2023 | -$78.0M | -23.1% |
| FY2022 | -$63.3M | -174.5% |
| FY2021 | -$23.1M | +22.9% |
| FY2020 | -$29.9M | -487.5% |
| FY2019 | -$5.1M | -159.6% |
| FY2018 | $8.5M | -56.8% |
| FY2017 | $19.8M | +228.0% |
| FY2016 | $6.0M | +296.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026